Ausgabe 2/2010
Inhalt (35 Artikel)
Association of rare MSH6 variants with familial breast cancer
Marijke Wasielewski, Muhammad Riaz, Joyce Vermeulen, Ans van den Ouweland, Ineke Labrijn-Marks, Renske Olmer, Linda van der Spaa, Jan G. M. Klijn, Hanne Meijers-Heijboer, Dennis Dooijes, Mieke Schutte
A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: in vitro and in vivo activity and mechanisms of action
Wei Wang, Elizabeth R. Rayburn, Sadanandan E. Velu, Deng Chen, Dwayaja H. Nadkarni, Srinivasan Murugesan, Dongquan Chen, Ruiwen Zhang
Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy
Kathryn N. Phoenix, Frank Vumbaca, Melissa M. Fox, Rebecca Evans, Kevin P. Claffey
ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole
Martin Smollich, Martin Götte, Jeanett Fischgräbe, Luciana F. Macedo, Angela Brodie, Shiuan Chen, Isabel Radke, Ludwig Kiesel, Pia Wülfing
UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer
Wei Jin, Li Chen, Ying Chen, Si-guang Xu, Gen-hong Di, Wen-jin Yin, Jiong Wu, Zhi-ming Shao
RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo
Xi-Xi Cao, Jing-Da Xu, Jia-Wen Xu, Xiao-Li Liu, Yuan-Yuan Cheng, Wen-Juan Wang, Qing-Quan Li, Qi Chen, Zu-De Xu, Xiu-Ping Liu
Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cells
Amelia D’Alessio, Antonella De Luca, Monica R. Maiello, Luana Lamura, Anna Maria Rachiglio, Maria Napolitano, Marianna Gallo, Nicola Normanno
Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ
M. Sharma, A. H. Beck, J. A. Webster, I. Espinosa, K. Montgomery, S. Varma, M. van de Rijn, K. C. Jensen, R. B. West
Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in mice
Reginald M. Gorczynski, Zhiqi Chen, Jun Diao, Ismat Khatri, Karrie Wong, Kai Yu, Julia Behnke
Physical activity levels after treatment for breast cancer: one-year follow-up
Nele Devoogdt, Marijke Van Kampen, Inge Geraerts, Tina Coremans, Steffen Fieuws, Johan Lefevre, Renaat Philippaerts, Steven Truijen, Patrick Neven, Marie-Rose Christiaens
Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
Christopher Lobo, Gilberto Lopes, Odalys Baez, Aurelio Castrellon, Annapoorna Ferrell, Connie Higgins, Erin Hurley, Judith Hurley, Isildinha Reis, Stephen Richman, Pearl Seo, Orlando Silva, Joyce Slingerland, Keleni Tukia, Catherine Welsh, Stefan Glück
Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial
Isabell Witzel, Sibylle Loibl, Gunter von Minckwitz, Christoph Mundhenke, Jens Huober, Claus Hanusch, Stephan Henschen, Maik Hauschild, Tilmann Lantzsch, Hans Tesch, Kunibert Latos, Marianne Just, Jörn Hilfrich, Jana Barinoff, Christine zu Eulenburg, Marc Roller, Michael Untch, Volkmar Müller
Corticosteroid treatment and timing of surgery in idiopathic granulomatous mastitis confusing with breast carcinoma
Fazilet Erozgen, Yeliz E. Ersoy, Murat Akaydin, Naim Memmi, Aysun Simsek Celik, Fatih Celebi, Deniz Guzey, Rafet Kaplan
Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)
Kathleen I. Pritchard, Janusz Rolski, Zsuzsanna Papai, Louis Mauriac, Fatima Cardoso, Jose Chang, Lawrence Panasci, Carmen Ianuli, Zsuzsanna Kahan, Kenjiro Fukase, Justin P. O. Lindemann, Merran P. Macpherson, Patrick Neven
Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer
H. Wildiers, C. Fontaine, P. Vuylsteke, M. Martens, J. L. Canon, W. Wynendaele, C. Focan, J. De Greve, P. Squifflet, R. Paridaens
A pilot study of adjuvant nanoparticle albumin-bound (nab) paclitaxel and cyclophosphamide, with trastuzumab in HER2-positive patients, in the treatment of early-stage breast cancer
Denise Yardley, Howard Burris III, Nancy Peacock, Eric Raefsky, Marianne Melnik, Roger Inhorn, Dianna Shipley, John Hainsworth
Depressive symptoms among young breast cancer survivors: the importance of reproductive concerns
Jessica R. Gorman, Vanessa L. Malcarne, Scott C. Roesch, Lisa Madlensky, John P. Pierce
BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects
Li-Xin Qiu, Lei Yao, Kai Xue, Jian Zhang, Chen Mao, Bo Chen, Ping Zhan, Hui Yuan, Xi-Chun Hu
Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer
Kerryn W. Reding, Jonine L. Bernstein, Bryan M. Langholz, Leslie Bernstein, Robert W. Haile, Colin B. Begg, Charles F. Lynch, Patrick Concannon, Ake Borg, Sharon N. Teraoka, Therese Törngren, Anh Diep, Shanyan Xue, Lisbeth Bertelsen, Xiaolin Liang, Anne S. Reiner, Marinela Capanu, Kathleen E. Malone
Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls
Xiaowei Qi, Xiangyu Ma, Xinhua Yang, Linjun Fan, Yi Zhang, Fan Zhang, Li Chen, Yan Zhou, Jun Jiang
Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study
Marilyn L. Kwan, Isaac Joshua Ergas, Carol P. Somkin, Charles P. Quesenberry Jr., Alfred I. Neugut, Dawn L. Hershman, Jeanne Mandelblatt, Michael P. Pelayo, Allegra W. Timperi, Sunita Q. Miles, Lawrence H. Kushi
Genetic variants on chromosome 5p12 are associated with risk of breast cancer in African American women: the Black Women’s Health Study
Edward A. Ruiz-Narvaez, Lynn Rosenberg, Charles N. Rotimi, L. Adrienne Cupples, Deborah A. Boggs, Adebowale Adeyemo, Yvette C. Cozier, Lucile L. Adams-Campbell, Julie R. Palmer
Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the breast cancer family registry
Theresa H. M. Keegan, Roger L. Milne, Irene L. Andrulis, Ellen T. Chang, Meera Sangaramoorthy, Kelly-Anne Phillips, Graham G. Giles, Pamela J. Goodwin, Carmel Apicella, John L. Hopper, Alice S. Whittemore, Esther M. John
Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects
Li-Xin Qiu, Lei Yao, Chen Mao, Bo Chen, Ping Zhan, Hui Yuan, Kai Xue, Jian Zhang, Xi-Chun Hu
MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls
Jian Zhang, Li-Xin Qiu, Zhong-Hua Wang, Xiang-Hua Wu, Xiao-Jian Liu, Bi-Yun Wang, Xi-Chun Hu
NBS1 8360G > C polymorphism is associated with breast cancer risk: a meta-analysis
Zhanwei Wang, Dan Cui, Weiquan Lu
TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects
Li-Xin Qiu, Lei Yao, Chen Mao, Bo Chen, Ping Zhan, Kai Xue, Jian Zhang, Hui Yuan, Xi-Chun Hu
Extremely low-frequency electromagnetic fields exposure and female breast cancer risk: a meta-analysis based on 24,338 cases and 60,628 controls
Chunhai Chen, Xiangyu Ma, Min Zhong, Zhengping Yu
The association between HSD17B1 Ser312Gly polymorphism and breast cancer risk: a meta-analysis including 31,053 subjects
Lei Yao, Li-huan Cao, Li-Xin Qiu, Long Yu
Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families
Zsofia K. Stadler, Emmanuel Saloustros, Nichole A. L. Hansen, Alice E. Schluger, Noah D. Kauff, Kenneth Offit, Mark E. Robson
Identification of a new complex deleterious mutation in exon 18 of the BRCA2 gene in a hereditary male/female breast cancer family
Orland Diez, Sara Gutiérrez-Enríquez, Miriam Masas, Anna Tenés, Carme Yagüe, Angels Arcusa, Gemma Llort
Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase
Kristy A. Brown, Nicole I. Hunger, Maria Docanto, Evan R. Simpson
Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival
Wendy A. Woodward, Pauline T. Truong, Tse-Kuan Yu, Welela Tereffe, Julia Oh, George Perkins, Eric Strom, Funda Meric-Bernstam, Ana-Maria Gonzalez-Angulo, Caroline Speers, Joseph Ragaz, Thomas A. Buchholz
RAD50 gene mutations are not likely a risk factor for breast cancer in Poland
Maria Mosor, Iwona Ziółkowska-Suchanek, Krzysztof Rożnowski, Marta Baranowska, Danuta Januszkiewicz-Lewandowska, Jerzy Nowak
Expression of the stem cell marker ALDH1 in the normal breast of BRCA1 mutation carriers
Marise R. Heerma van Voss, Petra van der Groep, Joost Bart, Elsken van der Wall, Paul J. van Diest